Gilead Sciences Inc (NASDAQ:GILD)

111.71
Delayed Data
As of May 22
 +0.49 / +0.44%
Today’s Change
78.50
Today|||52-Week Range
116.83
+18.51%
Year-to-Date
Bristol-Myers' Opdivo Gets Positive Opinion from CHMP - Analyst Blog
2:40pm / Zacks.com
10 S&P 500 Companies to Have the Most Revenue Growth in 2015
May 20 / TheStreet.com
AstraZeneca, Amgen End Psoriasis Drug Brodalumab Deal - Analyst Blog
2:40pm / Zacks.com
Intercept Pharmaceuticals (ICPT) in Focus: Stock Tanks 16.1% - Tale of the Tape
May 20 / Zacks.com
Amgen's PCSK9 Inhibitor a Step Closer to EU Approval - Analyst Blog
9:41am / Zacks.com
How Celgene Stock Is Breaking All the Rules
May 20 / MotleyFool.com
The Best Business Model in Biotech
8:05am / MotleyFool.com
Endo to Acquire Par Pharma for $8.05B, Shares Down - Analyst Blog
May 19 / Zacks.com
FireEye, Gilead Sciences, and Aeropostale: Doug Kass' Views
1:03am / TheStreet.com
Regeneron/Sanofi Announce Positive Data on Dupilumab - Analyst Blog
May 19 / Zacks.com
Warren Buffett's Portfolio: 3 Biotech Stocks the Oracle of Omaha Could Love
May 24 / MotleyFool.com
Eleven Biotherapeutics Tanks after Eye Drug Fails Study - Analyst Blog
May 19 / Zacks.com
Healthcare Investment Opportunities for the Long Term
May 23 / MotleyFool.com
Theravance Biopharma Posts Positive Data on Velusetrag - Analyst Blog
May 19 / Zacks.com
Novartis Announces Positive Data on Oncology Drug Afinitor - Analyst Blog
May 22 / Zacks.com
Genomic Health's Loss Lingers, Profits Expected in 4Q15 - Analyst Blog
May 19 / Zacks.com
Kite Pharma Starts Dosing in Phase I/II Study on KTE-C19 - Analyst Blog
May 22 / Zacks.com
XBiotech's Xilonix Recommended for Colorectal Cancer Study - Analyst Blog
May 19 / Zacks.com
Why The US Consumer Is About To be Crushed: The Obamacare Inflationary Deluge Arrives
May 22 / Investing Channel
Lannett (LCI) Signs Deal to Acquire Silarx Pharmaceuticals - Analyst Blog
May 19 / Zacks.com
Market's Flat, But Some Stocks Are Moving
May 22 / TheStreet.com
Celgene/Accelreon's Luspatercept Granted Fast Track Status - Analyst Blog
May 19 / Zacks.com
Should You Get Rid of CytRx Corporation (CYTR) Now? - Tale of the Tape
May 22 / Zacks.com
Apple, Gilead, JPMorgan Look Cheap
May 19 / TheStreet.com
J&J (JNJ) to File for More than 10 New Products by 2019 - Analyst Blog
May 21 / Zacks.com
Merck KGaA Q1 Earnings Fall Y/Y, 2015 Sales View Retained - Analyst Blog
May 19 / Zacks.com
Johnson & Johnson Just Stepped Up Its Hepatitis C Game
May 21 / MotleyFool.com
Stock Market News for May 19, 2015 - Market News
May 19 / Zacks.com
Bristol-Myers' HCV Combination Designation Amended by FDA - Analyst Blog
May 21 / Zacks.com
Jim Cramer -- Stock Market's Takeover Frenzy Won't End Anytime Soon
May 19 / TheStreet.com
MannKind, Front and Center: The Best Product Doesnbt Always Equal the Best Stock
May 21 / MotleyFool.com
Eleven Biotherapeutics (EBIO) in Focus: Stock Tanks 69.2% - Tale of the Tape
May 19 / Zacks.com
Following Hepatitis C, This Could Be the Next Disease Researchers Cure
May 21 / MotleyFool.com
3 Best Biotech Stocks to Add to Your Portfolio
May 19 / TheStreet.com
Johnson & Johnson Takes On Gilead Sciences in Hep C... Again
May 20 / MotleyFool.com
Gilead Sciences Buying Achillion Was Twitter Speculation at its Finest
May 19 / TheStreet.com
Intercept Pharmaceuticals Reveals Phase III OCA Study Plan - Analyst Blog
May 20 / Zacks.com
The Best Blue Chips to Own Forever
May 18 / MotleyFool.com
Achillion and Johnson & Johnson in $1.1B HCV Tie-Up - Analyst Blog
May 20 / Zacks.com
Alnylam Files Clinical Trial Application for ALN-AAT - Analyst Blog
May 18 / Zacks.com
Why Achillion Pharmaceuticals, Inc. Shares Are Collapsing
May 20 / MotleyFool.com
Why Achillion Pharmaceuticals, Inc. Shares Soared Today
May 18 / MotleyFool.com
America's 10 fastest-growing big companies
May 20 / CNNMoney.com
AbbVie's Humira Gets FDA Orphan Status for Skin Disease - Analyst Blog
May 18 / Zacks.com
5 NASDAQ Healthcare Stocks With The Highest EPS
May 20 / Benzinga
3 Biotechs That Are Worth Buying
May 18 / TheStreet.com
Zacks.com featured expert Kevin Matras highlights: Outerwall, Gilead Sciences, Lionbr...
May 20 / Zacks.com
Kite Pharma Narrows Q1 Loss, Misses Estimates; Gives View - Analyst Blog
May 18 / Zacks.com
SWOT Analysis of Gilead Sciences Inc. Stock
May 20 / MotleyFool.com
Gilead Sciences (GILD) Stock: 3 Reasons Why It Is a Top Choice for Growth Investors -...
May 18 / Zacks.com

To view my watchlist

Not a member yet?

Sign up now for a free account